Søk
Viser treff 1-1 av 1
Hyperglycemia, Assessed by HbA1c, and Future Risk of Venous Thromboembolism - The Tromsø Study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014-03-05)
Background: Glycated hemoglobin (HbA1c), a marker of average plasma glucose
during the last 8-12 weeks, is associated with future risk of cardiovascular disease
(CVD) and all-cause mortality.
Objectives: To examine the association between hyperglycemia, assessed by
HbA1c, and future risk of VTE in a population based cohort.
Methods: HbA1c was measured in 16 156 unique subjects (25-87 years) ...